This is a news story, published by Yahoo Finance, that relates primarily to Anne Wojcicki's news.
For more Anne Wojcicki's news, you can click here:
more Anne Wojcicki's newsFor more longevity news, you can click here:
more longevity newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about longevity, you might also like this article about
potential investors. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest test kits news, CEO Anne Wojcicki news, news about longevity, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
23andMeReuters
•81% Informative
Genetic testing firm 23andMe will not go ahead with CEO Anne Wojcicki's take-private offer.
The company has asked her to withdraw any plan to oppose any alternative deal, the company said on Friday .
A special committee formed by the company rejected the CEO's proposal as it saw the offer as insufficient.
VR Score
91
Informative language
96
Neutral language
77
Article tone
informal
Language
English
Language complexity
62
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links